SB
REGN icon

Simmons Bank’s Regeneron Pharmaceuticals REGN Stock Holding History

Simmons Bank’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.05M Buy
3,946
+820
+26% +$628K 0.2% 120
2025
Q4 		$2.41M Buy
+3,126
New +$2.12M 0.16% 132

Other funds holding REGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Simmons Bank's REGN Position: Q1 2026 in Review

Simmons Bank increased its Regeneron Pharmaceuticals (REGN) stake by 26% in Q1 2026, buying an estimated $628K and bringing the position to 3,946 shares worth $3.05M. The position accounts for 0.2% of the portfolio, ranked #120.

Simmons Bank first reported a position in REGN in Q4 2025 and has held it in 2 quarters since. 1,392 funds tracked by Wall St. Rank hold REGN as of Q1 2026.

  • Simmons Bank held 3,946 shares of Regeneron Pharmaceuticals worth $3.05M as of Q1 2026.
  • Simmons Bank bought 820 Regeneron Pharmaceuticals shares in Q1 2026, an estimated $628K.
  • Regeneron Pharmaceuticals made up 0.2% of Simmons Bank's portfolio in Q1 2026, its #120 holding.
  • Simmons Bank first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 1,392 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q1 2026.

Based on Simmons Bank's 13F filing for Q1 2026, filed 23 Apr 2026.